Hypertriglyceridemia

Excerpt

Hypertriglyceridemia (HTG) is increasingly becoming common in the medical world. Hypertriglyceridemia has been associated with an increased risk of cardiovascular disease and pancreatitis. A severe elevation of triglycerides (TG) increases the risk for pancreatitis and requires lowering by lifestyle change and pharmacotherapy. Also, etiology needs to be addressed. Although statin therapy targeting low-density cholesterol (LDL-C) has improved atherosclerotic cardiovascular disease (ASCVD) outcomes, residual risk remains. In the setting of residual atherosclerotic cardiovascular disease risk, multiple studies have shown that mild to moderate hypertriglyceridemia (HTG) is an independent risk factor for cardiovascular disease (CVD), but data does not show definite evidence that cardiovascular disease risk diminishes with the treatment of hypertriglyceridemia.